Patents by Inventor Neal Cheng

Neal Cheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibody agents specific for human CD19 and uses thereof
    Patent number: 11981742
    Abstract: Described herein are human antibody agents and multi-specific binding agents that specifically bind human CD 19, in particular, native human CD 19. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by CD 19 expression, in particular, B cell lymphomas and leukemias.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: May 14, 2024
    Assignee: Eureka Therapeutics, Inc.
    Inventors: Hong Liu, Jingwei Lu, Zhiyuan Yang, Li Long, Neal Cheng
  • FENESTRATION UNIT HAVING INTEGRATED POWER INTERFACE FOR PERIPHERAL DEVICES
    Publication number: 20240146046
    Abstract: A fenestration unit for a dwelling is disclosed. The fenestration unit, in the form of a window unit or a door unit includes a frame supporting a movable panel. A power supply module includes a battery pack disposed in one of the frame and the moveable panel. A power outlet module is also mounted in one of the frame and the movable panel. The power outlet module has a power outlet connector electrically coupled to the battery pack and is configured to resist water penetration therein. A homeowner device may be electrically coupled to the power outlet connector such that the power supply module powers the homeowner device.
    Type: Application
    Filed: November 2, 2022
    Publication date: May 2, 2024
    Applicant: JELD-WEN, Inc.
    Inventors: Yuxuan Gong, Qingzheng Cheng, Paul Hemingfield, Neal Hambleton
  • ANTIBODY AGENTS SPECIFIC FOR HUMAN CD19 AND USES THEREOF
    Publication number: 20190315859
    Abstract: Described herein are human antibody agents and multi-specific binding agents that specifically bind human CD 19, in particular, native human CD 19. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by CD 19 expression, in particular, B cell lymphomas and leukemias.
    Type: Application
    Filed: April 18, 2019
    Publication date: October 17, 2019
    Inventors: HONG LIU, Jingwei Lu, Zhiyuan Yang, Li Long, Neal Cheng
  • Antibody agents specific for human CD19 and uses thereof
    Patent number: 10301388
    Abstract: Described herein are human antibody agents and multi-specific binding agents that specifically bind human CD 19, in particular, native human CD 19. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by CD 19 expression, in particular, B cell lymphomas and leukemias.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: May 28, 2019
    Assignee: Eureka Therapeutics, Inc.
    Inventors: Hong Liu, Jingwei Lu, Zhiyuan Yang, Li Long, Neal Cheng
  • ANTIBODY AGENTS SPECIFIC FOR HUMAN CD19 AND USES THEREOF
    Publication number: 20180134787
    Abstract: Described herein are human antibody agents and multi-specific binding agents that specifically bind human CD 19, in particular, native human CD 19. Also provided herein are methods of using the same or compositions thereof for the detection, prevention and/or therapeutic treatment of diseases characterized by CD 19 expression, in particular, B cell lymphomas and leukemias.
    Type: Application
    Filed: December 13, 2017
    Publication date: May 17, 2018
    Inventors: HONG LIU, Jingwei Lu, Zhiyuan Yang, Li Long, Neal Cheng